Manchester Clinical Research Centre

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Fatty liver disease (MASLD/MASH)
• Liver cirrhosis

Running trials

• Active, not recruiting

  A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

  NCT03900429· Phase 3· Madrigal Pharmaceuticals, Inc.· Source